4-Bromo-2-chloro-5-(trifluoromethyl)pyridine

Catalog No.: 
ACLHYZ825
CAS No.: 
1211520-18-1
Molecular Formula: 
C6H2BrClF3N
Molecular Weight: 
260.44
4-Bromo-2-chloro-5-(trifluoromethyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$66.00In stockInquiry
1g95%$168.00In stockIn stock
5g95%$589.00In stockIn stock
10g95%$943.00In stockIn stock
25g95%$2263.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-2-chloro-5-(trifluoromethyl)pyridine
IUPAC Name4-bromo-2-chloro-5-(trifluoromethyl)pyridine
MDL No.MFCD16609906
Molecular FormulaC6H2BrClF3N
Molecular Weight260.44
SMILESFC(C1=CN=C(Cl)C=C1Br)(F)F
InChI KeyYSGXLKGGFMPUJB-UHFFFAOYSA-N
Synonym4-BROMO-2-CHLORO-5-(TRIFLUOROMETHYL)PYRIDINE;Pyridine, 4-bromo-2-chloro-5-(trifluoromethyl)-;methyl 6-amino-8-cyanonicotinate
CAS No.1211520-18-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACLHYZ825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLHYZ825 route compound structure diagram
    ACLHYZ8251211520-18-1In Stock
  4. Then
  5. ACLHYZ825 route product structure diagram
    ACLHYZ8251211520-18-1In Stock
Inquiry

2. ACLHYZ825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLHYZ825 route product structure diagram
    ACLHYZ8251211520-18-1In Stock
Inquiry

3. ACLHYZ825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLHYZ825 route product structure diagram
    ACLHYZ8251211520-18-1In Stock
Inquiry

Comments (0)